CN100360559C - 一种蜈蚣草abc转运蛋白及其编码基因与应用 - Google Patents
一种蜈蚣草abc转运蛋白及其编码基因与应用 Download PDFInfo
- Publication number
- CN100360559C CN100360559C CNB2004100808575A CN200410080857A CN100360559C CN 100360559 C CN100360559 C CN 100360559C CN B2004100808575 A CNB2004100808575 A CN B2004100808575A CN 200410080857 A CN200410080857 A CN 200410080857A CN 100360559 C CN100360559 C CN 100360559C
- Authority
- CN
- China
- Prior art keywords
- sequence
- arsenic
- gene
- pvabct1
- ciliate desert
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 74
- 108010078791 Carrier Proteins Proteins 0.000 title claims abstract description 40
- 102000014914 Carrier Proteins Human genes 0.000 title claims abstract description 39
- 241000051984 Blepharidachne Species 0.000 title claims description 27
- 241000223782 Ciliophora Species 0.000 title claims description 27
- 229910052785 arsenic Inorganic materials 0.000 claims abstract description 97
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 claims abstract description 97
- 239000002773 nucleotide Substances 0.000 claims abstract description 19
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 19
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 14
- 125000000539 amino acid group Chemical group 0.000 claims abstract description 11
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 4
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 3
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 3
- 239000002157 polynucleotide Substances 0.000 claims abstract description 3
- 150000001413 amino acids Chemical group 0.000 claims description 22
- 230000014509 gene expression Effects 0.000 claims description 18
- 238000011109 contamination Methods 0.000 claims description 13
- 101150057622 grass gene Proteins 0.000 claims description 9
- 238000009396 hybridization Methods 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 6
- 239000002777 nucleoside Substances 0.000 claims description 5
- 125000003835 nucleoside group Chemical group 0.000 claims description 5
- 230000009261 transgenic effect Effects 0.000 claims description 5
- 230000011664 signaling Effects 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 10
- 238000009825 accumulation Methods 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 4
- 241000258920 Chilopoda Species 0.000 abstract 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 40
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 39
- 238000006243 chemical reaction Methods 0.000 description 34
- 241000196324 Embryophyta Species 0.000 description 33
- 239000002299 complementary DNA Substances 0.000 description 24
- 239000002689 soil Substances 0.000 description 24
- 230000032258 transport Effects 0.000 description 22
- 230000006870 function Effects 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 235000001014 amino acid Nutrition 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 17
- 229910001385 heavy metal Inorganic materials 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 15
- 239000013598 vector Substances 0.000 description 14
- 238000002474 experimental method Methods 0.000 description 13
- 230000012010 growth Effects 0.000 description 13
- 108020004999 messenger RNA Proteins 0.000 description 13
- 239000007788 liquid Substances 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000006228 supernatant Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000011160 research Methods 0.000 description 9
- 101150089124 ACR3 gene Proteins 0.000 description 8
- 230000001580 bacterial effect Effects 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 210000005253 yeast cell Anatomy 0.000 description 8
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 7
- 108010085238 Actins Proteins 0.000 description 7
- AQLMHYSWFMLWBS-UHFFFAOYSA-N arsenite(1-) Chemical compound O[As](O)[O-] AQLMHYSWFMLWBS-UHFFFAOYSA-N 0.000 description 7
- 230000004087 circulation Effects 0.000 description 7
- 239000012634 fragment Substances 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000011259 mixed solution Substances 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 240000007594 Oryza sativa Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 241000737259 Pteris vittata Species 0.000 description 5
- 125000003275 alpha amino acid group Chemical group 0.000 description 5
- 229910052793 cadmium Inorganic materials 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 244000291564 Allium cepa Species 0.000 description 4
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 4
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000124033 Salix Species 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 229940000489 arsenate Drugs 0.000 description 4
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 238000003900 soil pollution Methods 0.000 description 4
- 108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 3
- 102000007469 Actins Human genes 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 206010005003 Bladder cancer Diseases 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 3
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 3
- 102000003960 Ligases Human genes 0.000 description 3
- 108090000364 Ligases Proteins 0.000 description 3
- CWHJIJJSDGEHNS-MYLFLSLOSA-N Senegenin Chemical compound C1[C@H](O)[C@H](O)[C@@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)C(CC[C@]4(CCC(C[C@H]44)(C)C)C(O)=O)=C4[C@@H](CCl)C[C@@H]3[C@]21C CWHJIJJSDGEHNS-MYLFLSLOSA-N 0.000 description 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 3
- 230000001351 cycling effect Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 108010050848 glycylleucine Proteins 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011535 reaction buffer Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000003757 reverse transcription PCR Methods 0.000 description 3
- 201000000849 skin cancer Diseases 0.000 description 3
- 201000008261 skin carcinoma Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 239000009871 tenuigenin Substances 0.000 description 3
- 230000010474 transient expression Effects 0.000 description 3
- 201000005112 urinary bladder cancer Diseases 0.000 description 3
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 3
- 102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 2
- 108010019485 Bacteria histidine permease Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- 108010090461 DFG peptide Proteins 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 102100022887 GTP-binding nuclear protein Ran Human genes 0.000 description 2
- 101000774835 Heteractis crispa PI-stichotoxin-Hcr2o Proteins 0.000 description 2
- 101000620756 Homo sapiens GTP-binding nuclear protein Ran Proteins 0.000 description 2
- VAXBXNPRXPHGHG-BJDJZHNGSA-N Ile-Ala-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)O)N VAXBXNPRXPHGHG-BJDJZHNGSA-N 0.000 description 2
- 244000285963 Kluyveromyces fragilis Species 0.000 description 2
- 235000014663 Kluyveromyces fragilis Nutrition 0.000 description 2
- OIARJGNVARWKFP-YUMQZZPRSA-N Leu-Asn-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O OIARJGNVARWKFP-YUMQZZPRSA-N 0.000 description 2
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- 108090001099 Multi drug resistance-associated proteins Proteins 0.000 description 2
- 102000004855 Multi drug resistance-associated proteins Human genes 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101100109981 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARR3 gene Proteins 0.000 description 2
- 101100393821 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GSP2 gene Proteins 0.000 description 2
- 231100000987 absorbed dose Toxicity 0.000 description 2
- 230000003044 adaptive effect Effects 0.000 description 2
- 108010047857 aspartylglycine Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- WLZRMCYVCSSEQC-UHFFFAOYSA-N cadmium(2+) Chemical compound [Cd+2] WLZRMCYVCSSEQC-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- DVUATXGAAOINPS-UHFFFAOYSA-N dimethoxyarsinic acid Chemical compound CO[As](O)(=O)OC DVUATXGAAOINPS-UHFFFAOYSA-N 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- 108010034529 leucyl-lysine Proteins 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- FRLCRPUWDUKNGO-UHFFFAOYSA-N methoxyarsonic acid Chemical compound CO[As](O)(O)=O FRLCRPUWDUKNGO-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000005065 mining Methods 0.000 description 2
- 230000009456 molecular mechanism Effects 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000012882 sequential analysis Methods 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 230000004960 subcellular localization Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- CNKBMTKICGGSCQ-ACRUOGEOSA-N (2S)-2-[[(2S)-2-[[(2S)-2,6-diamino-1-oxohexyl]amino]-1-oxo-3-phenylpropyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CNKBMTKICGGSCQ-ACRUOGEOSA-N 0.000 description 1
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 1
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 1
- JBVSSSZFNTXJDX-YTLHQDLWSA-N Ala-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)N JBVSSSZFNTXJDX-YTLHQDLWSA-N 0.000 description 1
- ODWSTKXGQGYHSH-FXQIFTODSA-N Ala-Arg-Ala Chemical compound C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O ODWSTKXGQGYHSH-FXQIFTODSA-N 0.000 description 1
- JYEBJTDTPNKQJG-FXQIFTODSA-N Ala-Asn-Met Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N JYEBJTDTPNKQJG-FXQIFTODSA-N 0.000 description 1
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 1
- QUIGLPSHIFPEOV-CIUDSAMLSA-N Ala-Lys-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O QUIGLPSHIFPEOV-CIUDSAMLSA-N 0.000 description 1
- VHEVVUZDDUCAKU-FXQIFTODSA-N Ala-Met-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O VHEVVUZDDUCAKU-FXQIFTODSA-N 0.000 description 1
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 1
- XQNRANMFRPCFFW-GCJQMDKQSA-N Ala-Thr-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C)N)O XQNRANMFRPCFFW-GCJQMDKQSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 101100161875 Arabidopsis thaliana ACR2 gene Proteins 0.000 description 1
- 101100495264 Arabidopsis thaliana CDC25 gene Proteins 0.000 description 1
- JGDGLDNAQJJGJI-AVGNSLFASA-N Arg-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N JGDGLDNAQJJGJI-AVGNSLFASA-N 0.000 description 1
- JSHVMZANPXCDTL-GMOBBJLQSA-N Arg-Asp-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JSHVMZANPXCDTL-GMOBBJLQSA-N 0.000 description 1
- TTXYKSADPSNOIF-IHRRRGAJSA-N Arg-Asp-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O TTXYKSADPSNOIF-IHRRRGAJSA-N 0.000 description 1
- PNQWAUXQDBIJDY-GUBZILKMSA-N Arg-Glu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PNQWAUXQDBIJDY-GUBZILKMSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- WVNFNPGXYADPPO-BQBZGAKWSA-N Arg-Gly-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O WVNFNPGXYADPPO-BQBZGAKWSA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- GSUFZRURORXYTM-STQMWFEESA-N Arg-Phe-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 GSUFZRURORXYTM-STQMWFEESA-N 0.000 description 1
- HRCIIMCTUIAKQB-XGEHTFHBSA-N Arg-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)O HRCIIMCTUIAKQB-XGEHTFHBSA-N 0.000 description 1
- VLIJAPRTSXSGFY-STQMWFEESA-N Arg-Tyr-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 VLIJAPRTSXSGFY-STQMWFEESA-N 0.000 description 1
- UEONJSPBTSWKOI-CIUDSAMLSA-N Asn-Gln-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O UEONJSPBTSWKOI-CIUDSAMLSA-N 0.000 description 1
- OOWSBIOUKIUWLO-RCOVLWMOSA-N Asn-Gly-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O OOWSBIOUKIUWLO-RCOVLWMOSA-N 0.000 description 1
- IKLAUGBIDCDFOY-SRVKXCTJSA-N Asn-His-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O IKLAUGBIDCDFOY-SRVKXCTJSA-N 0.000 description 1
- YYSYDIYQTUPNQQ-SXTJYALSSA-N Asn-Ile-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YYSYDIYQTUPNQQ-SXTJYALSSA-N 0.000 description 1
- BXUHCIXDSWRSBS-CIUDSAMLSA-N Asn-Leu-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O BXUHCIXDSWRSBS-CIUDSAMLSA-N 0.000 description 1
- IDUUACUJKUXKKD-VEVYYDQMSA-N Asn-Pro-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O IDUUACUJKUXKKD-VEVYYDQMSA-N 0.000 description 1
- HMQDRBKQMLRCCG-GMOBBJLQSA-N Asp-Arg-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HMQDRBKQMLRCCG-GMOBBJLQSA-N 0.000 description 1
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 1
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 1
- LDLZOAJRXXBVGF-GMOBBJLQSA-N Asp-Ile-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N LDLZOAJRXXBVGF-GMOBBJLQSA-N 0.000 description 1
- GKWFMNNNYZHJHV-SRVKXCTJSA-N Asp-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O GKWFMNNNYZHJHV-SRVKXCTJSA-N 0.000 description 1
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 1
- QJHOOKBAHRJPPX-QWRGUYRKSA-N Asp-Phe-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 QJHOOKBAHRJPPX-QWRGUYRKSA-N 0.000 description 1
- JUWISGAGWSDGDH-KKUMJFAQSA-N Asp-Phe-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(O)=O)CC1=CC=CC=C1 JUWISGAGWSDGDH-KKUMJFAQSA-N 0.000 description 1
- ZBYLEBZCVKLPCY-FXQIFTODSA-N Asp-Ser-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ZBYLEBZCVKLPCY-FXQIFTODSA-N 0.000 description 1
- MGSVBZIBCCKGCY-ZLUOBGJFSA-N Asp-Ser-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MGSVBZIBCCKGCY-ZLUOBGJFSA-N 0.000 description 1
- 102100038385 Coiled-coil domain-containing protein R3HCC1L Human genes 0.000 description 1
- 241001453651 Cyclosorus Species 0.000 description 1
- DZSICRGTVPDCRN-YUMQZZPRSA-N Cys-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N DZSICRGTVPDCRN-YUMQZZPRSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 1
- NNQHEEQNPQYPGL-FXQIFTODSA-N Gln-Ala-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NNQHEEQNPQYPGL-FXQIFTODSA-N 0.000 description 1
- JKPGHIQCHIIRMS-AVGNSLFASA-N Gln-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N JKPGHIQCHIIRMS-AVGNSLFASA-N 0.000 description 1
- IWUFOVSLWADEJC-AVGNSLFASA-N Gln-His-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O IWUFOVSLWADEJC-AVGNSLFASA-N 0.000 description 1
- QFXNFFZTMFHPST-DZKIICNBSA-N Gln-Phe-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(=O)N)N QFXNFFZTMFHPST-DZKIICNBSA-N 0.000 description 1
- UGEZSPWLJABDAR-KKUMJFAQSA-N Gln-Tyr-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCC(=O)N)N UGEZSPWLJABDAR-KKUMJFAQSA-N 0.000 description 1
- ZZLDMBMFKZFQMU-NRPADANISA-N Gln-Val-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O ZZLDMBMFKZFQMU-NRPADANISA-N 0.000 description 1
- UTKICHUQEQBDGC-ACZMJKKPSA-N Glu-Ala-Cys Chemical compound C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCC(=O)O)N UTKICHUQEQBDGC-ACZMJKKPSA-N 0.000 description 1
- VTTSANCGJWLPNC-ZPFDUUQYSA-N Glu-Arg-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VTTSANCGJWLPNC-ZPFDUUQYSA-N 0.000 description 1
- MLCPTRRNICEKIS-FXQIFTODSA-N Glu-Asn-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O MLCPTRRNICEKIS-FXQIFTODSA-N 0.000 description 1
- UMIRPYLZFKOEOH-YVNDNENWSA-N Glu-Gln-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UMIRPYLZFKOEOH-YVNDNENWSA-N 0.000 description 1
- UGSVSNXPJJDJKL-SDDRHHMPSA-N Glu-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N UGSVSNXPJJDJKL-SDDRHHMPSA-N 0.000 description 1
- FBEJIDRSQCGFJI-GUBZILKMSA-N Glu-Leu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O FBEJIDRSQCGFJI-GUBZILKMSA-N 0.000 description 1
- SJJHXJDSNQJMMW-SRVKXCTJSA-N Glu-Lys-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O SJJHXJDSNQJMMW-SRVKXCTJSA-N 0.000 description 1
- ZQYZDDXTNQXUJH-CIUDSAMLSA-N Glu-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)N ZQYZDDXTNQXUJH-CIUDSAMLSA-N 0.000 description 1
- CBEUFCJRFNZMCU-SRVKXCTJSA-N Glu-Met-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O CBEUFCJRFNZMCU-SRVKXCTJSA-N 0.000 description 1
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 1
- KIEICAOUSNYOLM-NRPADANISA-N Glu-Val-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KIEICAOUSNYOLM-NRPADANISA-N 0.000 description 1
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- YZACQYVWLCQWBT-BQBZGAKWSA-N Gly-Cys-Arg Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YZACQYVWLCQWBT-BQBZGAKWSA-N 0.000 description 1
- DTRUBYPMMVPQPD-YUMQZZPRSA-N Gly-Gln-Arg Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DTRUBYPMMVPQPD-YUMQZZPRSA-N 0.000 description 1
- GDOZQTNZPCUARW-YFKPBYRVSA-N Gly-Gly-Glu Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O GDOZQTNZPCUARW-YFKPBYRVSA-N 0.000 description 1
- VAXIVIPMCTYSHI-YUMQZZPRSA-N Gly-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN VAXIVIPMCTYSHI-YUMQZZPRSA-N 0.000 description 1
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 1
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 1
- FJWSJWACLMTDMI-WPRPVWTQSA-N Gly-Met-Val Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O FJWSJWACLMTDMI-WPRPVWTQSA-N 0.000 description 1
- SCJJPCQUJYPHRZ-BQBZGAKWSA-N Gly-Pro-Asn Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O SCJJPCQUJYPHRZ-BQBZGAKWSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- WGVPDSNCHDEDBP-KKUMJFAQSA-N His-Asp-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WGVPDSNCHDEDBP-KKUMJFAQSA-N 0.000 description 1
- LBQAHBIVXQSBIR-HVTMNAMFSA-N His-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N LBQAHBIVXQSBIR-HVTMNAMFSA-N 0.000 description 1
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 1
- VFBZWZXKCVBTJR-SRVKXCTJSA-N His-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N VFBZWZXKCVBTJR-SRVKXCTJSA-N 0.000 description 1
- NKRWVZQTPXPNRZ-SRVKXCTJSA-N His-Met-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CC1=CN=CN1 NKRWVZQTPXPNRZ-SRVKXCTJSA-N 0.000 description 1
- HJUPAYWVVVRYFQ-PYJNHQTQSA-N His-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC1=CN=CN1)N HJUPAYWVVVRYFQ-PYJNHQTQSA-N 0.000 description 1
- 101000619805 Homo sapiens Peroxiredoxin-5, mitochondrial Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- JXUGDUWBMKIJDC-NAKRPEOUSA-N Ile-Ala-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JXUGDUWBMKIJDC-NAKRPEOUSA-N 0.000 description 1
- YKRYHWJRQUSTKG-KBIXCLLPSA-N Ile-Ala-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKRYHWJRQUSTKG-KBIXCLLPSA-N 0.000 description 1
- RPZFUIQVAPZLRH-GHCJXIJMSA-N Ile-Asp-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)O)N RPZFUIQVAPZLRH-GHCJXIJMSA-N 0.000 description 1
- VQUCKIAECLVLAD-SVSWQMSJSA-N Ile-Cys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N VQUCKIAECLVLAD-SVSWQMSJSA-N 0.000 description 1
- WZDCVAWMBUNDDY-KBIXCLLPSA-N Ile-Glu-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](C)C(=O)O)N WZDCVAWMBUNDDY-KBIXCLLPSA-N 0.000 description 1
- PNDMHTTXXPUQJH-RWRJDSDZSA-N Ile-Glu-Thr Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@H](O)C)C(=O)O PNDMHTTXXPUQJH-RWRJDSDZSA-N 0.000 description 1
- HPCFRQWLTRDGHT-AJNGGQMLSA-N Ile-Leu-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O HPCFRQWLTRDGHT-AJNGGQMLSA-N 0.000 description 1
- PWUMCBLVWPCKNO-MGHWNKPDSA-N Ile-Leu-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PWUMCBLVWPCKNO-MGHWNKPDSA-N 0.000 description 1
- FTUZWJVSNZMLPI-RVMXOQNASA-N Ile-Met-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N FTUZWJVSNZMLPI-RVMXOQNASA-N 0.000 description 1
- YCKPUHHMCFSUMD-IUKAMOBKSA-N Ile-Thr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCKPUHHMCFSUMD-IUKAMOBKSA-N 0.000 description 1
- 244000283207 Indigofera tinctoria Species 0.000 description 1
- ZRLUISBDKUWAIZ-CIUDSAMLSA-N Leu-Ala-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O ZRLUISBDKUWAIZ-CIUDSAMLSA-N 0.000 description 1
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 1
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- USLNHQZCDQJBOV-ZPFDUUQYSA-N Leu-Ile-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O USLNHQZCDQJBOV-ZPFDUUQYSA-N 0.000 description 1
- JKSIBWITFMQTOA-XUXIUFHCSA-N Leu-Ile-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O JKSIBWITFMQTOA-XUXIUFHCSA-N 0.000 description 1
- YOKVEHGYYQEQOP-QWRGUYRKSA-N Leu-Leu-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YOKVEHGYYQEQOP-QWRGUYRKSA-N 0.000 description 1
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 1
- JVTYXRRFZCEPPK-RHYQMDGZSA-N Leu-Met-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)N)O JVTYXRRFZCEPPK-RHYQMDGZSA-N 0.000 description 1
- WXDRGWBQZIMJDE-ULQDDVLXSA-N Leu-Phe-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCSC)C(O)=O WXDRGWBQZIMJDE-ULQDDVLXSA-N 0.000 description 1
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 1
- LFSQWRSVPNKJGP-WDCWCFNPSA-N Leu-Thr-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(O)=O LFSQWRSVPNKJGP-WDCWCFNPSA-N 0.000 description 1
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 1
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 1
- JCFYLFOCALSNLQ-GUBZILKMSA-N Lys-Ala-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JCFYLFOCALSNLQ-GUBZILKMSA-N 0.000 description 1
- KNKHAVVBVXKOGX-JXUBOQSCSA-N Lys-Ala-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KNKHAVVBVXKOGX-JXUBOQSCSA-N 0.000 description 1
- IRRZDAIFYHNIIN-JYJNAYRXSA-N Lys-Gln-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IRRZDAIFYHNIIN-JYJNAYRXSA-N 0.000 description 1
- GJJQCBVRWDGLMQ-GUBZILKMSA-N Lys-Glu-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O GJJQCBVRWDGLMQ-GUBZILKMSA-N 0.000 description 1
- LPAJOCKCPRZEAG-MNXVOIDGSA-N Lys-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCCCN LPAJOCKCPRZEAG-MNXVOIDGSA-N 0.000 description 1
- ODUQLUADRKMHOZ-JYJNAYRXSA-N Lys-Glu-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)O ODUQLUADRKMHOZ-JYJNAYRXSA-N 0.000 description 1
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 1
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 1
- HVAUKHLDSDDROB-KKUMJFAQSA-N Lys-Lys-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HVAUKHLDSDDROB-KKUMJFAQSA-N 0.000 description 1
- ATNKHRAIZCMCCN-BZSNNMDCSA-N Lys-Lys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N ATNKHRAIZCMCCN-BZSNNMDCSA-N 0.000 description 1
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 1
- URBJRJKWSUFCKS-AVGNSLFASA-N Lys-Met-Arg Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCCN)N URBJRJKWSUFCKS-AVGNSLFASA-N 0.000 description 1
- ZCWWVXAXWUAEPZ-SRVKXCTJSA-N Lys-Met-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZCWWVXAXWUAEPZ-SRVKXCTJSA-N 0.000 description 1
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 1
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 1
- XGZDDOKIHSYHTO-SZMVWBNQSA-N Lys-Trp-Glu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CNC2=C1 XGZDDOKIHSYHTO-SZMVWBNQSA-N 0.000 description 1
- BLIPQDLSCFGUFA-GUBZILKMSA-N Met-Arg-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O BLIPQDLSCFGUFA-GUBZILKMSA-N 0.000 description 1
- XMMWDTUFTZMQFD-GMOBBJLQSA-N Met-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCSC XMMWDTUFTZMQFD-GMOBBJLQSA-N 0.000 description 1
- JYCQGAGDJQYEDB-GUBZILKMSA-N Met-Gln-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O JYCQGAGDJQYEDB-GUBZILKMSA-N 0.000 description 1
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100022078 Peroxiredoxin-5, mitochondrial Human genes 0.000 description 1
- KAHUBGWSIQNZQQ-KKUMJFAQSA-N Phe-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 KAHUBGWSIQNZQQ-KKUMJFAQSA-N 0.000 description 1
- XEXSSIBQYNKFBX-KBPBESRZSA-N Phe-Gly-His Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1N=CNC=1)C(O)=O)C1=CC=CC=C1 XEXSSIBQYNKFBX-KBPBESRZSA-N 0.000 description 1
- WFHRXJOZEXUKLV-IRXDYDNUSA-N Phe-Gly-Tyr Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 WFHRXJOZEXUKLV-IRXDYDNUSA-N 0.000 description 1
- PPHFTNABKQRAJV-JYJNAYRXSA-N Phe-His-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PPHFTNABKQRAJV-JYJNAYRXSA-N 0.000 description 1
- IFMDQWDAJUMMJC-DCAQKATOSA-N Pro-Ala-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O IFMDQWDAJUMMJC-DCAQKATOSA-N 0.000 description 1
- DIFXZGPHVCIVSQ-CIUDSAMLSA-N Pro-Gln-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O DIFXZGPHVCIVSQ-CIUDSAMLSA-N 0.000 description 1
- AQGUSRZKDZYGGV-GMOBBJLQSA-N Pro-Ile-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O AQGUSRZKDZYGGV-GMOBBJLQSA-N 0.000 description 1
- WVXQQUWOKUZIEG-VEVYYDQMSA-N Pro-Thr-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O WVXQQUWOKUZIEG-VEVYYDQMSA-N 0.000 description 1
- 241000736301 Pteridaceae Species 0.000 description 1
- 241000737257 Pteris <genus> Species 0.000 description 1
- 101150069124 RAN1 gene Proteins 0.000 description 1
- 101100380266 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ARR2 gene Proteins 0.000 description 1
- 101100355633 Salmo salar ran gene Proteins 0.000 description 1
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- HBOABDXGTMMDSE-GUBZILKMSA-N Ser-Arg-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O HBOABDXGTMMDSE-GUBZILKMSA-N 0.000 description 1
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 1
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 1
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 1
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- LRZLZIUXQBIWTB-KATARQTJSA-N Ser-Lys-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LRZLZIUXQBIWTB-KATARQTJSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- 238000003723 Smelting Methods 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- UKBSDLHIKIXJKH-HJGDQZAQSA-N Thr-Arg-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O UKBSDLHIKIXJKH-HJGDQZAQSA-N 0.000 description 1
- PAOYNIKMYOGBMR-PBCZWWQYSA-N Thr-Asn-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N)O PAOYNIKMYOGBMR-PBCZWWQYSA-N 0.000 description 1
- NLSNVZAREYQMGR-HJGDQZAQSA-N Thr-Asp-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NLSNVZAREYQMGR-HJGDQZAQSA-N 0.000 description 1
- XFTYVCHLARBHBQ-FOHZUACHSA-N Thr-Gly-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O XFTYVCHLARBHBQ-FOHZUACHSA-N 0.000 description 1
- IMULJHHGAUZZFE-MBLNEYKQSA-N Thr-Gly-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IMULJHHGAUZZFE-MBLNEYKQSA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- GYUUYCIXELGTJS-MEYUZBJRSA-N Thr-Phe-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O GYUUYCIXELGTJS-MEYUZBJRSA-N 0.000 description 1
- XKWABWFMQXMUMT-HJGDQZAQSA-N Thr-Pro-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O XKWABWFMQXMUMT-HJGDQZAQSA-N 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- VFURAIPBOIWAKP-SZMVWBNQSA-N Trp-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N VFURAIPBOIWAKP-SZMVWBNQSA-N 0.000 description 1
- LHHDBONOFZDWMW-AAEUAGOBSA-N Trp-Asp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N LHHDBONOFZDWMW-AAEUAGOBSA-N 0.000 description 1
- VMBBTANKMSRJSS-JSGCOSHPSA-N Trp-Glu-Gly Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O VMBBTANKMSRJSS-JSGCOSHPSA-N 0.000 description 1
- CYLQUSBOSWCHTO-BPUTZDHNSA-N Trp-Val-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N CYLQUSBOSWCHTO-BPUTZDHNSA-N 0.000 description 1
- WTXQBCCKXIKKHB-JYJNAYRXSA-N Tyr-Arg-Arg Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WTXQBCCKXIKKHB-JYJNAYRXSA-N 0.000 description 1
- IXTQGBGHWQEEDE-AVGNSLFASA-N Tyr-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IXTQGBGHWQEEDE-AVGNSLFASA-N 0.000 description 1
- FBHBVXUBTYVCRU-BZSNNMDCSA-N Tyr-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CN=CN1 FBHBVXUBTYVCRU-BZSNNMDCSA-N 0.000 description 1
- QPBJXNYYQTUTDD-KKUMJFAQSA-N Tyr-Met-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QPBJXNYYQTUTDD-KKUMJFAQSA-N 0.000 description 1
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 1
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 1
- VLOYGOZDPGYWFO-LAEOZQHASA-N Val-Asp-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VLOYGOZDPGYWFO-LAEOZQHASA-N 0.000 description 1
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 1
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 1
- ZLMFVXMJFIWIRE-FHWLQOOXSA-N Val-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](C(C)C)N ZLMFVXMJFIWIRE-FHWLQOOXSA-N 0.000 description 1
- DFQZDQPLWBSFEJ-LSJOCFKGSA-N Val-Val-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DFQZDQPLWBSFEJ-LSJOCFKGSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- LLJLBRRXKZTTRD-GUBZILKMSA-N Val-Val-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)O)N LLJLBRRXKZTTRD-GUBZILKMSA-N 0.000 description 1
- 101150004068 acrB gene Proteins 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 108010005233 alanylglutamic acid Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 108010007483 arginyl-leucyl-tyrosyl-glutamic acid Proteins 0.000 description 1
- 150000001495 arsenic compounds Chemical class 0.000 description 1
- 239000005442 atmospheric precipitation Substances 0.000 description 1
- 238000007622 bioinformatic analysis Methods 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 231100000762 chronic effect Toxicity 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- PWGQHOJABIQOOS-UHFFFAOYSA-N copper;dioxido(dioxo)chromium Chemical compound [Cu+2].[O-][Cr]([O-])(=O)=O PWGQHOJABIQOOS-UHFFFAOYSA-N 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012268 genome sequencing Methods 0.000 description 1
- 108010049041 glutamylalanine Proteins 0.000 description 1
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 1
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010033719 glycyl-histidyl-glycine Proteins 0.000 description 1
- 108010020688 glycylhistidine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010081551 glycylphenylalanine Proteins 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 229940093920 gynecological arsenic compound Drugs 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 108010072591 lysyl-leucyl-alanyl-arginine Proteins 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 108010085203 methionylmethionine Proteins 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000036457 multidrug resistance Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 239000008239 natural water Substances 0.000 description 1
- 238000001216 nucleic acid method Methods 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000000361 pesticidal effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 230000004983 pleiotropic effect Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000031539 regulation of cell division Effects 0.000 description 1
- 230000008521 reorganization Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000003161 ribonuclease inhibitor Substances 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 108010048818 seryl-histidine Proteins 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000003802 soil pollutant Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 108010061238 threonyl-glycine Proteins 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 210000003934 vacuole Anatomy 0.000 description 1
- 239000005418 vegetable material Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种蜈蚣草ABC转运蛋白及其编码基因与应用。本发明的蜈蚣草ABC转运蛋白,其氨基酸残基序列如序列表中的序列2所示。其编码基因是下述核苷酸序列之一:1)序列表中序列1的多核苷酸序列;2)在高严谨条件下可与序列表中序列1限定的DNA序列杂交的核苷酸序列。本发明的蜈蚣草ABC转运蛋白基因在砷的吸收和积累中起重要作用,将在修复砷污染环境的生物技术中起到重要作用。
Description
技术领域
本发明涉及一种蜈蚣草ABC转运蛋白及其编码基因与应用,特别涉及一种蜈蚣草ABC转运蛋白及其编码基因,与该基因在治理砷污染中的应用。
背景技术
土壤是人类赖以生存的自然资源,但是,由于生活污水排放、污水灌溉、大气沉降、采矿冶炼、农药化肥大量施用等原因,加上土壤对于污染物的累积富集作用,土壤污染,尤其是重金属污染状况日趋严重。
传统的土壤污染治理方法主要有:基于机械物理或物理化学原理的工程措施,包括客土换土法、隔离法、清洗法、热处理法、电化学法等;基于污染物土壤地球化学行为的改良措施,如添加改良剂、抑制剂降低土壤污染物的水溶性、扩散性和生物有效性,以减轻污染物对生态环境的危害。土壤污染治理的工程学方法往往需要将污染土壤挖运后处理,不仅耗资巨大,而且破坏了土壤微生物及土壤结构,对于大规模、中强度的污染治理几乎无法实现。
近十年来,植物修复(Phytoremediation)技术成为土壤污染修复研究的热点。植物修复是利用可超富集重金属的植物吸收、积累环境中的污染物,并降低其毒害的环保生物技术。它具有传统环境修复技术所不具备的优点,表现为:治理效果的永久性、治理过程的原位性(对土壤环境扰动小)、治理成本的低廉性、环境美学的兼容性、后期处理的简易性等特点,而且修复过程一般无二次污染,某些金属元素甚至可回收利用。植物修复所独有的技术及经济优势,预示该项技术将发展成为污染治理领域的朝阳产业。
植物修复为从根本上解决土壤和水体金属污染提供了一种重要途径,因而植物修复在土壤金属污染治理中具有独特的作用和意义。然而,植物修复技术目前尚存在着一些不足:其一是重金属超富集植物是在重金属胁迫环境下长期诱导、驯化的一种适应性突变体,往往生长缓慢、生物量低,且常常受到杂草的竞争性威胁;其二是这些超富集植物多为野生型稀有植物,对生物气候条件的要求比较严格,区域性分布较强,严格的适生性使成功引种受到严重限制;其三是超富集植物的专一性很强,往往只对某种特定的重金属表现出超富集能力,且大部分仍处于试验阶段,到实际应用还有一定距离。从而严重制约了植物修复的效率及应用。体积较小或呈莲座形生长的植物往往影响机械收获,使得年收获的费用增加。
植物修复的长远发展依赖于超富集植物分子机制的阐明和新型超富集工程植物的研发。分子生物学在植物修复研究和应用领域扮演着越来越重要的角色。在阐明超富集植物分子机制的基础上,应用转基因工程技术,将自然界中超累积植物的耐重金属、超累积基因移殖到生物量大、生长速率快的植物中去,培育出具有实用价值的转基因植物,以克服天然超累积植物的缺点,提高植物修复的实用性。到目前为止,在Se、Hg、Cd、Zn等重金属元素转基因植物研究领域已取得了较大的成果。随着分子生物技术的突飞猛进,预期这方面研究一定会取得突破性的进展。
砷是一种致癌的化学元素。砷污染物主要是以砷化物的形式存在,它可从呼吸道、食物或皮肤进入人体,严重危害人类健康。砷化物通过抑制体内酶的活性,干扰人体正常新陈代谢,从而导致中枢神经系统发生紊乱,毛细血管扩张。人们若长时间暴露在含砷环境中,则会大大增加患肝癌、皮肤癌或膀胱癌等恶性疾病的机率。现在越来越多的皮肤癌、肾癌、肺癌或膀胱癌等癌症患者与长期饮用含砷量高的水有关。饮用水中砷的长期慢性作用可导致皮肤产生严重的色素沉着现象并且手、脚生成角质物质,进一步恶化则变为皮肤癌。长期饮用含砷量高的水,患肺癌、膀胱癌或其它癌症的几率高达10%。另外土壤和水体的砷污染还可导致粮食减产,从而造成严重的经济损失。天然水中仅含微量的砷,水中含砷量高,除了地质因素外,主要是工业废水和农药污染所致。面对全球砷污染的严重状况,亟需阐明超富集植物对砷吸收、转运和解毒的机理,研发出修复砷污染环境的生物技术,以尽快地消除土壤及水体的砷污染对人类健康的威胁。
然而,很久以来砷污染的植物修复技术一直是一个空白。直到2001年,Nature报道发现了世界上第一种能够大量富集砷的凤尾蕨属植物-蜈蚣草Pteris vittata L.,人们才开始对砷污染的植物修复技术进行研究。次年,陈同斌等在我国境内也发现了这种砷超富集植物。经研究表明,蜈蚣草具有典型的超富集植物的三大特征:高效的根部吸收、根到茎的高效转运,及植物细胞对砷的高抗性。蜈蚣草的地上部分可以富集22,630mg kg-1砷,比土壤中砷浓度的10倍还高。
蜈蚣草属蕨类植物门、凤尾蕨科风尾蕨属。这种植物的适应能力强,喜阳,多生长在碱性环境中。Ma等在佛罗里达州中部一个铬酸铜和砷酸盐污染的地区发现了这种蕨类植物。他们的研究表明在砷浓度高达1,500ppm(mg/kg)的土地上蜈蚣草仍然可以正常生长,蜈蚣草地上部在两周内富集的砷浓度可以从29.4ppm(mg/kg)增加到15,861ppm(mg/kg),生长在含砷6ppm(mg/kg)土地上的蜈蚣草可以富集755ppm(mg/kg)砷,其地上部富集的砷是土壤中的126倍。
Ma等在研究蜈蚣草中砷的形态时发现,生长20周的蜈蚣草植株中大部分砷都以强毒性的无机形态存在,几乎检测不到有机砷。地上部(47-80%)As(III)的浓度远远高于根部(8.3%),该结果表明当从根部运送到地上部时,砷从五价转变为三价。他们的研究还表明蜈蚣草不仅可以从不同浓度的土壤中清除砷,而且可以从土壤中清除不同形态的砷。此外,对于不能溶解的FeAsO4和AlAsO4,蜈蚣草地上部仍然可以富集136-315ppm(mg/L)砷,该浓度是土壤中砷浓度的3-6倍。Tu的研究结果也与之类似,在土壤中加入同一浓度不同形态的砷,包括砷酸盐(AsO4 3-)、亚砷酸盐(AsO2 1-)、二甲基砷酸(DMA)以及一甲基砷酸(MMA),18周后检测结果表明土壤中可溶性的砷只有砷酸盐,而蜈蚣草植株中94%的砷都是亚砷酸盐。但在老叶和离体叶片中,亚砷酸盐又被氧化成砷酸盐。
在许多植物中,含低分子量巯基的化合物(如PCs)在重金属的解毒和积累方面都起重要的作用。Zhao等的研究结果表明砷超富集植物蜈蚣草中只有1-3%的砷形成As(III)-(PC2)2复合物。这说明PCs在砷的解毒和积累方面起很有限的作用。
1982年,在Giovanna Ames的实验室克隆到了第一个ABC转运蛋白(ATP-bindingcassette(ABC)transporter)一组氨酸透性酶(histidine permease)。至此以后,不同的ABC转运蛋白不断被发现,并成为生物体中最大的蛋白家族之一。大多数ABC蛋白转运伴随着ATP水解,其转运底物很多,包括脂质、无机离子、有机复合物、氨基酸、小肽、糖、次级代谢产物及蛋白等。
根据系统发生途径及其结构特点,ABC转运蛋白又分为多个亚家族。研究较多的三个亚家族分别是多效抗药性亚家族(pleiotropic drug resistance,PDR)、广谱抗药性亚家族(multidrug resistance,MDR)以及广谱抗药性相关蛋白亚家族(multidrug resistance-associated protein,MRP)。
虽然ABC转运蛋白的底物种类繁多,但在结构和机理上有很多共性,即它们都是通过以ATP为能量来源的泵或通道来执行功能。一个完整的有功能的ABC转运蛋白包括两个核苷结合结构域(nucleotide-binding domains,NBDs或ABC结构域)和两个跨膜结构域(transmembrane domains,TMDs)。NBD通常存在于细胞质中,具有与ATP结合的区域,TMD通常含有6个α螺旋跨膜区。了解ABC转运蛋白的蛋白结构对于研究ATP水解与底物转运的协同工作机理具有重要意义。
拟南芥的基因组研究发现,拟南芥基因组中共包含131个ABC转运蛋白,其中有54个全长ABC转运蛋白(即包含两个疏水区和两个亲水区)。水稻基因组测序结果表明含有45个全长ABC转运蛋白。1993年,Martinoia等研究了大麦液泡对谷胱甘肽的吸收,此吸收过程是由一个ABC转运蛋白介导的。但大多数植物的ABC转运蛋白的功能尚不清楚。
目前为止,人们对植物砷抗性和超富集机理的了解还非常有限。蜈蚣草能够超富集砷是近年的一个新发现。但目前仅对蜈蚣草中砷的吸收、形态、分布有一些初步的了解,关于蜈蚣草对砷的超富集机理以及解毒机制还不清楚,也没有任何相关分子机制的报道。
酵母的基因组较为简单,酵母中重金属抗性基因的研究相对较为清楚。ACR3基因定位于酵母细胞质膜上,可以将酵母细胞内的亚砷酸盐转运到细胞外,对酵母亚砷酸盐的转运起重要的作用。FD236-6A即是缺失ACR3基因的突变菌株,该菌株对亚砷酸盐的敏感度是野生型菌株的5倍,在含超过0.3mM亚砷酸盐的YPD固体培养基中便不能生长。利用FD236-6A酵母菌株,通过功能互补实验可以验证其它生物来源的基因在砷抗性中的功能。
发明内容
本发明的目的是提供一种蜈蚣草ABC转运蛋白及其编码基因。
本发明所提供的蜈蚣草ABC转运蛋白,名称为PvABCT1,来源于蜈蚣草(Pterisvittata L.)是具有下述氨基酸残基序列之一的蛋白质:
1)序列表中的序列2;
2)将序列表中序列2的氨基酸残基序列经过一至十个氨基酸残基的取代、缺失或添加且具有砷吸收作用的蛋白质。
序列表中的序列2由597个氨基酸残基组成。
编码上述蜈蚣草ABC转运蛋白的基因也属于本发明的保护范围。
蜈蚣草ABC转运蛋白基因,命名为PvABCT1,可具有以下核苷酸序列之一:
1)序列表中序列1的多核苷酸序列;
2)与序列表中序列1限定的核苷酸序列具有90%以上同源性且具有相同活性的核苷酸序列;
3)在高严谨条件下可与序列表中序列1限定的DNA序列杂交的核苷酸序列。
所述高严谨条件为杂交后用含0.1×SSPE(或0.1×SSC)、0.1%SDS的溶液在65℃下洗膜。
序列表中的序列1由2165个碱基组成,其编码序列为自序列1的5’端第163-1956位核苷酸。
含有本发明基因的表达载体、细胞系,如pESPM/PvABCT1,pGFP-2/PvABCT1和含有pESPM/PvABCT1的FD236-6A酵母菌株均属于本发明的保护范围。
扩增上述蜈蚣草ABC转运蛋白基因中任一片段的引物对也在本发明的保护范围之内。
PvABCT1具有两个ABC转运蛋白核苷结合结构域——ATP结合结构域,分别位于自N端第105-112位氨基酸残基和417-424位氨基酸残基;两个很小的跨膜结构域,分别位于序列表中序列2的自N端第252-257位氨基酸残基和自N端第515-519位氨基酸残基;ABC转运蛋白家族的信号区,位于序列表中序列2的自N端第217-231位氨基酸残基;ABC转运蛋白家族特征结构域,位于自N端第73-313位氨基酸残基。表明PvABCT1是一个ABC转运蛋白。同时对PvABCT1蛋白进行疏水性分析,表明该蛋白具有很强的亲水性,无明显的疏水区域。
在实际应用中,可通过将蜈蚣草ABC转运蛋白基因转入其它生物量大、生长速率快的植物中,培育出具有富集砷特性的转基因植物,以克服天然超累积植物的缺点,提高植物修复的实用性。
研究表明本发明的蜈蚣草ABC转运蛋白基因在砷的吸收和积累中起重要作用,因而将在修复砷污染环境的生物技术中起到重要作用,以尽快消除土壤及水体的砷污染对人类健康的威胁,同时对其它重金属环境污染的治理也具有重要的启示意义,本发明具有较大的实际意义。
附图说明
图1为蜈蚣草ABC转运蛋白序列的同源序列检索的结果
图2A为经不同重金属处理的蜈蚣草PvABCT1基因转录水平表达变化柱状图
图2B为经不同重金属处理的蜈蚣草PvABCT1基因转录水平表达的电泳图
图3为三种酵母菌株对砷吸收量的测定结果
具体实施方式
实施例1、PvABCT1及其编码基因PvABCT1的获得
一、砷处理蜈蚣草的SSH文库的构建
1、蜈蚣草的砷处理
蜈蚣草(Pteris vittata L.)采自湖北省矿区,移栽在温室培养。取未经砷处理的蜈蚣草嫩叶(对照)和经5mM NaAsO2处理4周后的蜈蚣草嫩叶(盆栽条件下,在土壤中加入NaAsO2溶液,使其终浓度为5mM,处理4周后取嫩叶),用液氮速冻后保存于-70℃待用。
2、蜈蚣草RNA的提取
用改进的RNA提取方法分别提取步骤1中未经处理的和用NaAsO2处理后的蜈蚣草的总RNA,具体步骤如下:
1)将0.5ml提取缓冲液A(含100mmol/L Tris-HCl,pH8.3;500mmol/L EDTA,pH8.3;500mmol/L NaCl,2%SDS,5mmol/L DTT)加入到1.5ml离心管中,加入1.5%体积的β-巯基乙醇;
2)将100mg蜈蚣草叶片用液氮冷冻研磨后,迅速转到温浴的离心管中,剧烈震荡离心管,使组织与提取缓冲液A充分混匀,70℃温浴6min,迅速置于冰上;
3)待混合物冷却后,12000g离心10min,小心取出上清液;
4)将上清液中加入0.1ml 5mol/L NaCl,混匀后,加入溶液1/2体积的水饱和酚和1/2体积的氯仿,置于震荡器上剧烈震荡2min,12000g离心10min,小心取出上清液;
5)向上清液中加入1/4体积的2-丁氧乙醇和1.5%体积的β-巯基乙醇,混匀,冰浴10min;
6)将混合物2000g离心10min,小心取出上清液;
7)向上清液中加入等体积的2-丁氧乙醇和1.5%体积的β-巯基乙醇,充分混匀后静置10min,12000g离心10min,弃上清,沉淀即为总RNA;
8)将步骤7)中的沉淀用50%的2-丁氧乙醇洗涤两次,加入适量的DEPC处理水溶解总RNA。
3、mRNA的纯化及浓缩
1)使用Oligotex mRNA Spin-Column Kit(Clontech公司)并参照其说明书分别对步骤1获得的未经砷处理和经砷处理蜈蚣草的总RNA进行纯化,得到含有未经砷处理和经砷处理蜈蚣草mRNA的溶液;
2)将含有经砷处理的蜈蚣草mRNA的溶液中加入1/10体积的3M NaAc和2倍体积的乙醇。-20℃下放置1h;8000g离心15min,弃上清;向沉淀中加1ml 70%乙醇,混匀后8000g离心15min,弃上清;将沉淀在空气中干燥10min,用不含核酸酶的蒸镏水溶解,得到砷处理蜈蚣草mRNA的浓缩液;
3)用与步骤2)相同的方法得到含有未经砷处理蜈蚣草mRNA的浓缩液。
4、抑制性消减杂交(suppression subtractive hybridization,SSH)文库的构建及同源序列的检索与比较
以步骤3获得的砷处理蜈蚣草的mRNA为实验方(tester)、未经砷处理蜈蚣草的mRNA为驱动方(driver),使用Clontech PCR-SelectTM cDNA Subtraction Kit(Clontech公司)并参照其说明书按常规方法得到实验方和驱动方的SSH PCR产物。
将实验方和驱动方经消减杂交后的抑制性PCR产物克隆至载体pGEM-Teasy(Promega公司)中,建立两个差异SSH文库,具体步骤如下:
1)将实验方和驱动方消减杂交后的抑制性PCR产物用T4 DNA连接酶(TaKaRa公司)分别与载体pGEM-Teasy连接,形成重组载体,将含有实验方抑制性PCR产物基因的重组载体命名为pGEM-Tester,将含有驱动方抑制性PCR产物基因的重组载体命名为pGEM-Driver。
2)将重组载体pGEM-Tester和pGEM-Driver分别用CaCl2法转化大肠杆菌DH5α,将两种重组菌接种于LB抗性培养平板(含氨苄青霉素100μg/ml,浓度为20mg/ml的X-Gal 40μl,浓度为200mg/ml的IPTG 4μl)进行蓝白筛选,挑取白色单菌落为模板,用菌落PCR的方法做进一步筛选,PCR反应体系如下:
灭菌水 16.5μl
10×PCR反应缓冲液 2μl
dNTP(10mM) 0.5μl(TaKaRa公司)
SP6(20pmol/ml) 0.25μl(TaKaRa公司)
T7(20pmol/ml) 0.25 μl(TaKaRa公司)
rTaq DNA聚合酶 0.5μl(TaKaRa公司)
总共 20μl
PCR反应条件为:94℃ 25sec;94℃ 10sec,55℃ 30sec,72℃ 1.5min,27个循环。将PCR产物用1%琼脂糖凝胶电泳进行检测,选取阳性克隆,用双脱氧核糖核酸法进行测序。测序完毕后,在NCBI(htttp://www.ncbi.hlm.nib.gov/BLAST)的蛋白数据库(Blastp)中进行蛋白序列的同源序列检索,对其中一些序列进行保守结构域分析。结果在以砷处理蜈蚣草为实验方、未经砷处理蜈蚣草为驱动方的cDNA文库中,筛选到的一条385bp的cDNA片段,该片段含有ABC转运蛋白(ATP-bindingcassette transporter)的核苷结合结构域,并且与杨树、拟南芥、水稻的ABC转运蛋白基因的同源性都在80%以上。
二、RACE法克隆砷处理蜈蚣草PvABCT1及其编码基因Pv4BCT1
用SMARTTM RACE cDNA Amplification Kit(Clontech公司)参照说明书克隆出砷处理蜈蚣草ABC转运蛋白基因,具体步骤如下:
1、合成第一链cDNA
1)取2个PCR管,分别用来合成5’-RACE-Ready cDNA和3’RACE Ready cDNA,两个反应体系如下:
5’-RACE-Ready cDNA反应体系:
1μg砷处理蜈蚣草mRNA
1μl 5’-CDS引物(试剂盒中自带)
1μl SMART II A oligo(试剂盒中自带);
3’-RACE Ready cDNA反应体系:
1μg砷处理蜈蚣草mRNA
1μl 3’-CDS引物A(试剂盒中自带)
1μl SMART II A oligo(试剂盒中自带);
两个反应体系均用灭菌水补至5μl,混匀后离心;
2)用PCR仪70℃反应2分钟,冰浴2分钟,短暂离心;
3)将两个反应管中再分别加入以下试剂:
2μl 5×第一链缓冲液
1μl DTT(20mM)
1μl dNTP(10mM)
1μl PowerScript逆转录酶(试剂盒中自带);
混匀后离心;
4)用PCR仪42℃反应1.5个小时;
5)用Tricine-EDTA(试剂盒中自带)缓冲液将上述反应液稀释10倍;
6)用PCR仪72℃加热7分钟,获得第一链cDNA。
2、RACE反应
根据得到的砷处理蜈蚣草ABC转运蛋白基因片段的序列,设计合成了基因特异引物(Gene Specific Primer,GSP),分别为:
GSP1:5’-TATGTCCAAACCCGTGAAGAGCTGG-3’
GSP2:5’-GGTTTCAACAAAAGCATGCAACAG-3’
NGSP1:5’-CGGGATTTTTCAGGCGGCTGGAG-3’
NGSP2:5’-GGGATTTTTCAGGCGGCTGGAGA-3’
1)分别以GSP1和GSP2为引物进行5’-RACE和3’-RACE反应,均按说明书操作配置反应体系;反应条件如下:
5’-RACE反应条件为:95℃1min,64℃1min,72℃50sec,30个循环。
3’-RACE反应条件为:95℃1min,64℃1min,72℃2min,35个循环。
用1%琼脂糖凝胶电泳检测,表明5’RACE和3’RACE分别得到750bp和1500bp大小的条带,再用引物NGSP1和NGSP2进行验证,均得到预期长度的片段。然后对5’RACE和3’RACE片段进行测序,并根据测序的结果,即根据cDNA的5’端和3’端序列再次设计引物(引物序列如下),进行砷处理蜈蚣草ABC转运蛋白的cDNA全长基因的克隆。
引物3’-1:5’ CTACAAGAAGAAAGTGTTATAAATATTGATCAGA3’
引物5’-1:5’ GCTTTTTAGTTTTCCCCAACCCTCA3’
砷处理蜈蚣草ABC转运蛋白的cDNA全长基因克隆的PCR反应体系如下:
灭菌水 15μl
蜈蚣草cDNA(1ng/μl) 1μl
10×LA PCR反应缓冲液 2μl(TaKaRa公司)
dNTP(10 mM) 0.5μl(TaKaRa公司)
引物3’-1(20pmol/ml) 0.5μl(上海博亚生物技术有限公司合成)
引物5’-1(20pmol/ml) 0.5μl(上海博亚生物技术有限公司合成)
LA Taq DNA聚合酶 0.5μl(TaKaRa公司)
总共 20μl
PCR循环条件为:95℃30sec,62℃30sec,72℃2.5min,30个循环。
3、砷处理蜈蚣草ABC转运蛋白基因的cDNA的序列分析
将步骤2克隆得到的砷处理蜈蚣草ABC转运蛋白的cDNA全长基因进行测序,将测序结果用DNAMAN4.0软件和NCBI的BLAST进行序列比较、同源性分析、疏水性分析以及结构域预测,并用PPSEARCH软件进行蛋白结构域的预测。
1)DNA测序结果表明:砷处理蜈蚣草ABC转运蛋白的eDNA序列全长为2165bp,具有序列表中序列1的核苷酸序列,其编码序列(开放阅读框架)长度为1794bp,是自序列1的5’端的第163-1956位核苷酸,编码具有序列表中序列2(597个氨基酸残基)的氨基酸残基序列的蛋白质。5’端的非翻译区长度为162bp,3’端的终止区长度为209bp,含一个长度为20bp的polyA尾。将该基因命名为PvABCT1,其编码蛋白命名为PvABCT1。
2)PvABCT1的蛋白序列分析及同源性比较
PvABCT1蛋白质的分子量约为67284kD,等电点为6.38。PvABCT1在数据库中与各种原核和真核生物的ABC转运蛋白有较高的同源性。如图1所示,PvABCT1氨基酸序列与杨树、拟南芥以及水稻ABC Transporter氨基酸序列比较,其同源性达80-85%。
3)PvABCT1的保守结构域分析
对PvABCT1进行生物信息学分析,结果表明:PvABCT1具有ABC转运蛋白家族的特征。其中自N端第217-231位氨基酸残基为ABC转运蛋白家族的信号区;自N端第105-112位氨基酸残基和417-424均为ATP结合结构域;自N端第73-313位氨基酸残基为ABC转运蛋白家族特征结构域。表明PvABCT1是一个ABC转运蛋白。
PvABCT1氨基酸序列在GenBank数据库中与各种原核和真核生物的ABC转运蛋白有较高的同源性。如图1所示,蜈蚣草PvABCT1氨基酸序列与杨树、拟南芥以及水稻ABC转运蛋白氨基酸序列比较,其同源性达80-85%。图1中,右边的数字表示每个氨基酸位置。黑色阴影部分表示相同的氨基酸残基。拟南芥、水稻、杨树转运蛋白在GenBank的序列号分别是NP 200887,BAC55994和AB041505.1。
4)PvABCT1蛋白的跨膜结构预测
通过PSORT软件对PvABCT1蛋白的跨膜结构进行预测,结果表明:PvABCT1具有两个ABC转运蛋白核苷结合结构域——ATP结合结构域,分别位于自N端第105-112位氨基酸残基和417-424位氨基酸残基;两个很小的跨膜结构域,分别位于序列表中序列2的自N端第252-257位氨基酸残基和自N端第515-519位氨基酸残基;ABC转运蛋白家族的信号区,位于序列表中序列2的自N端第217-231位氨基酸残基;ABC转运蛋白家族特征结构域,位于自N端第73-313位氨基酸残基。表明PvABCT1是一个ABC转运蛋白。同时对PvABCT1蛋白进行疏水性分析,表明该蛋白具有很强的亲水性,无明显的疏水区域。
实施例2、用RT-PCR的方法进行PvABCT1表达模式的研究
分别收集经5mM NaAsO2、1mM CdCl2和1mM CuSO4处理蜈蚣草4周的蜈蚣草嫩叶(盆栽条件下,在土壤中加入NaAsO2(使其终浓度为5mM)、CdCl2(使其终浓度为1mM)或CuSO4(使其终浓度为1mM)处理溶液,处理4周后取嫩叶),用液氮速冻后保存于-70℃,用于下述RT-PCR检测。
1、蜈蚣草actin基因片段的克隆:
根据拟南芥等植物actin基因的保守区设计一对简并引物,其序列为:
引物3:5’-TTTGCTGGAGATGATGCTCC-3’
引物4:5’-GTGGTACGACCACTGGCATA-3’
以蜈蚣草的cDNA为模板,进行PCR扩增,得到一条400 bp左右大小的条带,经测序并与其他植物的actin基因序列进行比较,证明它是蜈蚣草的actin基因片段。因为actin基因的表达比较稳定,不因外界环境刺激或组织不同而变化,是很好的RT-PCR的内参。
2、cDNA的合成:
应用mRNA选择性PCR试剂盒(mRNA Selective PCR Kit,购自TaKaRa)合成cDNA。其中,反转录反应体系为:
2×mRNA选择性PCR缓冲液(试剂盒中自带) 25μl
MgCl2(试剂盒中自带) 10μl
dNTP(试剂盒中自带) 5μl
RNase抑制剂(试剂盒中自带) 1μl
AMV反转录酶(试剂盒中自带) 1μl
下游特异引物(CAGTTCCAGTCTGACCGAAAG)(20pmol/ml) 1μl
不同重金属处理的蜈蚣草RNA(1μg/μl) 1μl
dH2O 6μl
反转录反应条件为:30℃10min,45℃30min,5℃5min。合成不同处理的cDNA。
3、PCR反应
根据PvABCT1的序列,设计一对特异引物:
引物5:5’ ATGGCGCTTGCGGGACTTTATCGT 3’
引物6:5’ CAGTTCCAGTCTGACCGAAAG 3’
以5mM NaAsO2、1mM CdCl2和1mM CuSO4处理的蜈蚣草cDNA为模板,按以下程序进行:95℃ 40秒,60℃ 50秒,72℃ 50秒,23个循环。
取等量的PCR产物进行电泳,电泳条带经凝胶成像系统Alphaimager(AlphaInnotech公司,型号:LCS NO.00182)扫描并积分定量。同法测定对应的actin基因表达量,所有数据均以actin的表达量取得一致,并将两者进行比较,得到不同处理的PvABCT1基因的表达差异。结果如图2A和图2B所示,表明在未经重金属处理的蜈蚣草叶片中,PvABCT1基因有较低水平的表达。蜈蚣草经过5mM Na3AsO3、1mM CdCl2以及1mM CuSO4处理后,该基因表达量均有所提高。砷处理条件下该基因的表达量是未处理的7倍,而铜离子和镉离子处理条件下其表达量是未处理的2倍左右。实验结果表明该基因的表达受砷的诱导,但铜离子和镉离子对其表达也有一定影响。图2A和2B中,CK表示对照,As表示经过5mM Na3AsO3处理,Cd表示经1mM CdCl2处理,Cu表示经1mM CuSO4处理。
实施例3、PvABCT1基因的亚细胞定位(基因瞬时表达)
1、瞬时表达载体的构建
引物序列如下:
引物7:5’GC
CTCGAGATGGCGTCAGATGCAA3’ (划线部分的核苷酸序列为XhoI)
引物8:5’CC
GGTACCAAGGCCTGCTTTTGCT3’ (划线部分的核苷酸序列为KpnI)
以蜈蚣草PvABCT1基因的全长cDNA为模板进行PCR反应,PCR反应体系为:
灭菌水 15μl
蜈蚣草cDNA(1 ng/μ l) 1μl
10×LA PCR反应缓冲液 2μl(TaKaRa公司)
dNTP(10mM) 0.5μl(TaKaRa公司)
引物7(20pmol/ml) 0.5μl(上海博亚生物技术有限公司合成)
引物8(20pmol/ml) 0.5μl(上海博亚生物技术有限公司合成)
LA Taq DNA聚合酶 0.5μl(TaKaRa公司)
总共 20μl
PCR循环条件为:95℃ 30sec,62℃ 30sec,72℃ 2.5min,30个循环。
经PCR反应,扩增出了PvABCT1,并在PvABCT1两端引入了XhoI和KpnI的酶切位点。将基因瞬时表达载体pGFP-2(M.J.Varagona,R.J.Schmidt and N.V.Raikhel,Nuclear localization signals required for nuclear targeting of the maizeregulatory protein Opaque-2.Plant Cell 4(1992),1213-1227.)与引入了XhoI和KpnI位点的PvABCT1用XhoI和KpnI进行双酶切,将酶切产物用玻璃奶回收试剂盒(博大泰克公司)回收后再用T4DNA连接酶连接,得到含有PvABCT1的重组载体pGFP-2/PvABCT1。将重组载体pGFP-2/PvABCT1用XhoI和KpnI限制性内切酶进行酶切鉴定,1%琼脂糖凝胶电泳结果表明构建的重组载体pGFP-2/PvABCT1正确。
2、植物材料准备
剥取洋葱内表皮于MS培养基中,室温放置备用。
3、转基因植物的制备及PvABCT1的亚细胞定位
将步骤1构建的含有PvABCT1的重组载体pGFP-2/PvABCT1及载体pGFP-2(对照)用基因枪转化法导入步骤2的洋葱表皮细胞中,导入后将其在MS培养基上培养24小时,然后用荧光显微镜或激光共聚焦显微镜观察绿色荧光蛋白基因(GFP)的表达情况。结果表明,GFP荧光在用pGFP-2轰击的洋葱表皮的整个表皮细胞中均可观察到。在用pGFP-2/PvABCT1轰击的洋葱表皮中,观察到的GFP荧光主要集中在细胞质中,从而证明PvABCT1是在细胞质中表达。
实施例4、酵母功能互补实验
利用FD236-6A酵母菌株(Bobrowicz P,Wysocki R,Owsianik G,Goffeau A,Ulaszewski S.Isolation of three contiguous genes,ACR1,ACR2 and ACR3,involved in resistance to arsenic compounds in the yeast Saccharomycescerevisiae.Yeast,1997,13:819-28.),通过功能互补实验以验证其它生物来源的基因在砷抗性中的功能。将PvABCT1基因转入对As敏感的酵母菌株FD236-6A中,分别检测其对砷、铜、镉三种重金属的抗性,以验证其是否能够互补ACR3基因的功能。
1、设计引物
引物序列如下:
引物9:5’GC
CTCGAGATGGCGTCAGATGCAA3’ (划线部分的核苷酸序列为XhoI)
引物10:5’AC
GGATCCTCAAAGGCCTGCTTTT3’ (划线部分的核苷酸序列为BamHI)
以蜈蚣草PvABCT1的全长cDNA为模板,在引物9和引物10的引导下进行PCR反应,PCR反应体系以及PCR循环条件同实施例1步骤二中的砷处理蜈蚣草ABC转运蛋白的cDNA全长基因克隆。经PCR反应,扩增出了PvABCT1,并在PvABCT1两端引入了XhoI和BamHI的酶切位点。将酵母超表达载体pESPM(Xin Wang,Wen-Zhong Xu,Yun-YuanXu,Kang Chong,Zhi-Hong Xu and Gui-Xian Xia,Wheat RAN1,a nuclear small Gprotein,is involved in regulation of cell division in yeast.Plant Science,2004:67,6,1183-1190)与引入XhoI和BamHI位点的PvABCT1用XhoI和BamHI限制性内切酶进行双酶切,将酶切产物用玻璃奶回收试剂盒(博大泰克公司)回收后再用T4DNA连接酶连接,得到含有PvABCT1的重组载体pESPM/PvABCT1。将重组载体pESPM/PvABCT1用XhoI和BamHI限制性内切酶进行酶切鉴定,1%琼脂糖凝胶电泳结果表明构建的重组载体pESPM/PvABCT1正确。
2、转化酵母
将构建的重组载体pESPM/PvABCT1转化酵母(FD236-6A),具体步骤如下:
1)将该酵母菌株接种于5ml液体YPD培养基中,30℃下振荡培养12-24小时;
2)测定培养物的细胞密度,当细胞密度达到约5×106个/ml时,将其接种于100ml液体YPD培养基中,30℃,200转/min继续振荡培养;
3)当细胞密度达到约2×107个/ml时,停止培养,3000g离心5min,收获细胞,弃培养液;
4)将收获的细胞悬浮于25ml无菌水中,3000g离心5min,收获细胞;
5)把收获的细胞悬浮在1ml的100mmol/L的醋酸锂中,将悬浮物转到一个无菌1.5ml的离心管中,离心5sec沉淀细胞,吸出醋酸锂;
6)用100mmol/L醋酸锂溶液悬浮细胞至终体积为500μl;
7)将1ml单链单体DNA样品(Clontech公司)煮沸5分钟,快速在冰水中冷却;
8)振荡步骤6)的细胞悬浮液,取50μl细胞悬浮液加到标记的离心管中,离心沉淀细胞,除去醋酸锂;
9)配制“转化混合液”,成分如下:
240μl PEG(50%)
36μl 1.0mol/L醋酸锂
25μl 单链载体DNA(2.0mg/ml)(Clontech公司)
50μl 水和质粒(含0.1-10μg的步骤1构建的载体pESPM/PvABCT1);剧烈振荡至每个反应管内的细胞完全混匀;
10)将转化混合液30℃保温30min;
11)将转化混合液42℃热激20-25min;
12)将转化混合液6000-8000g离心15秒,除去转化混合液;
13)将1-2ml的无菌水加到每个反应管中,轻轻悬浮沉淀。
3、筛选转化子
将200μl含有转化的酵母菌株FD236-6A的转化混合液涂到去除亮氨酸的SD(购于Clontech公司)培养平板30℃培养72小时筛选转化子。挑取阳性克隆,分别在含有300μmol/L As3+(用50mmol/L MES缓冲液配制)和500μmol/L As3+的1/2YPD培养基上划线培养,进行二次筛选。
以经两次筛选获得的阳性克隆为模板,用PvABCT1的特异引物进行菌落PCR鉴定。PvABCT1的特异引物序列为:
引物11:5’-ATGGCGCTTGCGGGACTTTATCGT-3’
引物12:5’-CAGTTCCAGTCTGACCGAAAG-3’
菌落PCR程序如下:95℃2min;95℃30sec,60℃30sec,72℃2min,30个循环;72℃10min。得到表达有PvABCT1基因的酵母菌株。
4、酵母抗性检测
利用酵母功能互补实验分别检测经过鉴定的转化子对砷、铜、镉三种重金属的抗性,结果表明在本实验条件下,FD236-6A酵母菌株在添加0.25mM NaAsO2的1/2YPD培养基中可以正常生长。PvABCT1转入到FD236-6A后,该酵母对砷的敏感性提高。在添加0.125mM NaAsO2的1/2YPD培养基中生长减慢,在0.25mM NaAsO2条件下该酵母就完全不能生长。酵母功能互补实验表明PvABCT1不仅不能与ACR3基因的功能互补,反而使酵母对砷的敏感性增加,说明PcABCT1基因的功能与ACR3基因不同。
同时还检测了把PvABCT1转入到FD236-6A后该酵母对铜、镉的抗性反应。结果表明在本实验条件下,FD236-6A酵母菌株在添加4mM CuSO4的1/2YPD培养基中可以正常生长,在添加6mM CuSO4的1/2YPD培养基中,FD236-6A酵母菌株生长减慢,在8mM CuSO4条件下该酵母就完全不能生长。而PvABCT1转入到FD236-6A后,在8mM CuSO4条件下该酵母还可以正常生长,说明PvABCT1基因的表达可以提高酵母细胞对铜的抗性,这可能是由于该基因与铜的转运有关。
该基因对酵母细胞镉的抗性无明显作用。
实施例5、PvABCT1功能的进一步验证
1、液体培养基中酵母砷的抗性检测
为进一步验证PvABCT1的功能,将对照菌株(FD236-6A酵母菌株)、插入空载体(pESPM)的菌株和表达PvABCT1基因的酵母菌株在1/2YPD液体培养基中30℃,200r/分钟培养至OD600=0.5,添加0.125mM砷于培养基中,继续培养24小时。分别测定它们的OD600值。测定结果表明,对照菌株、插入空载体的菌株和表达PvABCT1基因的酵母菌株在未添加砷的液体培养基中生长状况几乎一样。在添加0.125mM砷的培养基中,三个菌株的生长都受到了抑制,而表达PvABCT1基因的酵母菌株比对照菌株和插入空载体的菌株的生长明显缓慢,可见该基因的表达增加了酵母菌株的敏感性。
2、酵母对砷的吸收量测定
挑取对照菌株(FD236-6A酵母菌株)、插入空载体的酵母菌株(pESPM)和经上述菌落PCR鉴定表达有PvABCT1基因的酵母菌株分别接种于1/2YPD液体培养基中30℃,200r/分钟培养至OD600=0.5。添加0.125mM砷于培养基中,继续培养24小时。离心三种酵母细胞,收集上清,用10mM的EDTA将收集的酵母细胞洗涤三次,50℃烘干酵母细胞。消解矿化后用等离子体发射光谱仪(Induced coupled plasma,ICP)测定菌体中的砷含量。结果如图3所示,表明表达PvABCT1基因的酵母菌株在As含量为0.125mM的1/2YPD液体培养基中的生长24小时后,吸收砷的量是对照菌株和插入空载体菌株的1.73倍。这表明在转入该基因后,酵母细胞增强了对砷的吸收。FD236-A缺失了ACR3基因,向胞外运输砷能力减弱,PvABCT1基因的表达增加了酵母对砷的吸收,因而细胞更易受伤害。实验结果表明,该基因的功能与ACR3基因的功能不同,因而证明该基因与砷的吸收有关。
序列表
<160>2
<210>1
<211>2165
<212>DNA
<213>蜈蚣草(Pteris vittata L.)
<400>1
gctttttagt tttccccaac cctcaacgtt gtcgcggagg gaaaggccac cagttttgtt 60
caatttcgca aatcctgttc ttcctttgcg ctgtcgtctc agttgccgcc cttctacttg 120
caggaagaag ctcacgtaga agaaaatatt tagtgcagaa atatggcgtc agatgcaagc 180
aagaagaagg cagctcaaaa gaaggcagct gctgcagcta agcgcggttc caaagccact 240
gctactaatg caacctcgtc taaaactaat ggggtttcca attcatcccc aaatgaagtt 300
gcagatgaga tggcctatat gcagataact gataggacat gtacaggaat ccttgcttcc 360
catccacaat caagagatat tcatatcgaa agtctaacgg tgacatttca tggccatgat 420
ctcattgtag attcgagcct cgaactcaac tatagaaggc gttatggatt gcttgggctg 480
aatggttgtg gaaagtcgac tctcctgtca gccataggtt gccgtgagct acccattcca 540
gagcatatgg atatttacca tttaactcgg gaaattgaag caactgactt gacctctctg 600
caagccgttg taaacgtaga tgaagaaagg atcaagctag aaaaagaggc tgaaatgcta 660
gctgctcagg atgatggtgg tggtgaggtt ctagaaagat tatatgagcg tttggaggct 720
atggatgcag ctacagcaga gaagagggca gctgaaattt tgtatggtct gggtttcaac 780
aaaagcatgc aacagaagaa gacccgggat ttttcaggcg gctggagaat gaggattgca 840
ttagccagag cattgttcat gaacccaact attttactgc ttgatgaacc aacgaaccat 900
cttgatctcg aagcctgtgt gtggcttgag gaaacattga agaagtttga ccgcattctt 960
gtcgttgtat cacactctca ggattttctt aatggcatct gcacaaacat tatacatatg 1020
caaagtaaga agctgaagtt ctacacagga aattacgacc aatatgtcca aacccgtgaa 1080
gagctggaag aaaatcagat gaagcagtat aagtgggaac aagagcagat agcaaacatg 1140
aaagagtaca ttgccaggtt tgggcatggc tctgctaaac tagccaggca ggcacagagc 1200
aaggagaaga cattggcaaa gatggaaaga gggggtctca cagagagggt ggttaaggac 1260
aaggtgcttg ttttccgatt tactgacgtt ggcaagttac ccccaccagt tctacaattt 1320
gtggaggtgg actttggtta cactccagaa catatgatat acaagaaaat tgactttgga 1380
gttgacctgg attcgaggat agctttggtt ggtcccaatg gagcaggtaa gagcactctt 1440
ttgaagctta tgacgggcga attgtctccc attgatggca tggtgcggcg ccacaaccat 1500
ttacggattg cgcagtttca ccagcatttg gcagataagc tgaatcttga tatgcctgcc 1560
ctacagtaca tgatgtcgga atatcctggc ttagaagaag aaaagatgcg ggcagcgatt 1620
ggaaggtttg ggctgactgg aaaggctcaa atcatgccca tgagaaatct atccgacggt 1680
cagaggagtc gtgttatttt tgcttggtta gcttggcggt tacctcatat gctcctgctt 1740
gatgaaccta cgaatcatct tgatattgag acaatagatg ctttggctga tgcattaaat 1800
gaatgggatg gagggcttgt gcttgtgggt catgatttta ggcttatcaa ccaggtggcc 1860
aaggagatct gggtttgtga gaaccaaaca gtgtcaaggt gggaaggtga cattatggac 1920
ttcaaacagc acctaaaagc aaaagcaggc ctttgagatg gtgttgctta gaagattgaa 1980
cttgagaggc catagccata tctactttta ataaagtagt aaagattttg cttttgatat 2040
gaattattct caagatacga gaatgcctac ttggaagctc gtaatgaagc tttttatatt 2100
gcttcatcat ttctgatcaa tatttataac actttcttct tgtagaaaaa aaaaaaaaaa 2160
aaaaa 2165
<210>2
<211>597
<212>PRT
<213>蜈蚣草(Pteris vittata L.)
<400>2
Met Ala Ser Asp Ala Ser Lys Lys Lys Ala Ala Gln Lys Lys Ala Ala
1 5 10 15
Ala Ala Ala Lys Arg Gly Ser Lys Ala Thr Ala Thr Asn Ala Thr Ser
20 25 30
Ser Lys Thr Asn Gly Val Ser Asn Ser Ser Pro Asn Glu Val Ala Asp
35 40 45
Glu Met Ala Tyr Met Gln Ile Thr Asp Arg Thr Cys Thr Gly Ile Leu
50 55 60
Ala Ser His Pro Gln Ser Arg Asp Ile His Ile Glu Ser Leu Thr Val
65 70 75 80
Thr Phe His Gly His Asp Leu Ile Val Asp Ser Ser Leu Glu Leu Asn
85 90 95
Tyr Arg Arg Arg Tyr Gly Leu Leu Gly Leu Asn Gly Cys Gly Lys Ser
100 105 110
Thr Leu Leu Ser Ala Ile Gly Cys Arg Glu Leu Pro Ile Pro Glu His
115 120 125
Met Asp Ile Tyr His Leu Thr Arg Glu Ile Glu Ala Thr Asp Leu Thr
130 135 140
Ser Leu Gln Ala Val Val Asn Val Asp Glu Glu Arg Ile Lys Leu Glu
145 150 155 160
Lys Glu Ala Glu Met Leu Ala Ala Gln Asp Asp Gly Gly Gly Glu Val
165 170 175
Leu Glu Arg Leu Tyr Glu Arg Leu Glu Ala Met Asp Ala Ala Thr Ala
180 185 190
Glu Lys Arg Ala Ala Glu Ile Leu Tyr Gly Leu Gly Phe Asn Lys Ser
195 200 205
Met Gln Gln Lys Lys Thr Arg Asp Phe Ser Gly Gly Trp Arg Met Arg
210 215 220
Ile Ala Leu Ala Arg Ala Leu Phe Met Asn Pro Thr Ile Leu Leu Leu
225 230 235 240
Asp Glu Pro Thr Asn His Leu Asp Leu Glu Ala Cys Val Trp Leu Glu
245 250 255
Glu Thr Leu Lys Lys Phe Asp Arg Ile Leu Val Val Val Ser His Ser
260 265 270
Gln Asp Phe Leu Asn Gly Ile Cys Thr Asn Ile Ile His Met Gln Ser
275 280 285
Lys Lys Leu Lys Phe Tyr Thr Gly Asn Tyr Asp Gln Tyr Val Gln Thr
290 295 300
Arg Glu Glu Leu Glu Glu Asn Gln Met Lys Gln Tyr Lys Trp Glu Gln
305 310 315 320
Glu Gln Ile Ala Asn Met Lys Glu Tyr Ile Ala Arg Phe Gly His Gly
325 330 335
Ser Ala Lys Leu Ala Arg Gln Ala Gln Ser Lys Glu Lys Thr Leu Ala
340 345 350
Lys Met Glu Arg Gly Gly Leu Thr Glu Arg Val Val Lys Asp Lys Val
355 360 365
Leu Val Phe Arg Phe Thr Asp Val Gly Lys Leu Pro Pro Pro Val Leu
370 375 380
Gln Phe Val Glu Val Asp Phe Gly Tyr Thr Pro Glu His Met Ile Tyr
385 390 395 400
Lys Lys Ile Asp Phe Gly Val Asp Leu Asp Ser Arg Ile Ala Leu Val
405 410 415
Gly Pro Asn Gly Ala Gly Lys Ser Thr Leu Leu Lys Leu Met Thr Gly
420 425 430
Glu Leu Ser Pro Ile Asp Gly Met Val Arg Arg His Asn His Leu Arg
435 440 445
Ile Ala Gln Phe His Gln His Leu Ala Asp Lys Leu Asn Leu Asp Met
450 455 460
Pro Ala Leu Gln Tyr Met Met Ser Glu Tyr Pro Gly Leu Glu Glu Glu
465 470 475 480
Lys Met Arg Ala Ala Ile Gly Arg Phe Gly Leu Thr Gly Lys Ala Gln
485 490 495
Ile Met Pro Met Arg Asn Leu Ser Asp Gly Gln Arg Ser Arg Val Ile
500 505 510
Phe Ala Trp Leu Ala Trp Arg Leu Pro His Met Leu Leu Leu Asp Glu
515 520 525
Pro Thr Asn His Leu Asp Ile Glu Thr Ile Asp Ala Leu Ala Asp Ala
530 535 540
Leu Asn Glu Trp Asp Gly Gly Leu Val Leu Val Gly His Asp Phe Arg
545 550 555 560
Leu Ile Asn Gln Val Ala Lys Glu Ile Trp Val Cys Glu Asn Gln Thr
565 570 575
Val Ser Arg Trp Glu Gly Asp Ile Met Asp Phe Lys Gln His Leu Lys
580 585 590
Ala Lys Ala Gly Leu
595
Claims (8)
1、蜈蚣草ABC转运蛋白,其氨基酸残基序列如序列表中的序列2所示。
2、根据权利要求1所述的蛋白质,其特征在于:所述序列表中序列2具有两个ABC转运蛋白核苷结合结构域——ATP结合结构域,分别位于自N端第105-112位氨基酸残基和417-424位氨基酸残基;两个跨膜结构域,分别位于序列表中序列2的自N端第252-257位氨基酸残基和自N端第515-519位氨基酸残基;ABC转运蛋白家族的信号区,位于序列表中序列2的自N端第217-231位氨基酸残基;ABC转运蛋白家族特征结构域,位于自N端第73-313位氨基酸残基。
3、编码权利要求1所述蜈蚣草ABC转运蛋白的基因。
4、根据权利要求3所述的基因,其特征在于:所述蜈蚣草ABC转运蛋白基因是下述核苷酸序列之一:
1)序列表中序列1的多核苷酸序列;
2)在高严谨条件下可与序列表中序列1限定的DNA序列杂交的核苷酸序列。
5、根据权利要求4所述的基因,其特征在于:所述蜈蚣草ABC转运蛋白基因的编码序列为自序列1的5’端第163-1956位核苷酸。
6、含有权利要求3、4或5所述的蜈蚣草ABC转运蛋白基因的表达载体。
7、含有权利要求3、4或5所述的蜈蚣草ABC转运蛋白基因的转基因细胞系。
8、权利要求3、4或5所述的蜈蚣草ABC转运蛋白基因在治理砷污染中的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100808575A CN100360559C (zh) | 2004-10-12 | 2004-10-12 | 一种蜈蚣草abc转运蛋白及其编码基因与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100808575A CN100360559C (zh) | 2004-10-12 | 2004-10-12 | 一种蜈蚣草abc转运蛋白及其编码基因与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1760204A CN1760204A (zh) | 2006-04-19 |
CN100360559C true CN100360559C (zh) | 2008-01-09 |
Family
ID=36706447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100808575A Expired - Fee Related CN100360559C (zh) | 2004-10-12 | 2004-10-12 | 一种蜈蚣草abc转运蛋白及其编码基因与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100360559C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102190715A (zh) * | 2010-03-02 | 2011-09-21 | 中国科学院植物研究所 | 一种植物砷抗性相关的蛋白及编码基因及其应用 |
CN107475780A (zh) * | 2017-09-25 | 2017-12-15 | 中国计量大学 | 一种低温胁迫下福寿螺ssh文库的构建、鉴定方法 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102899348A (zh) * | 2012-10-17 | 2013-01-30 | 中国科学院植物研究所 | PvARRP1蛋白及其编码基因在砷转运解毒和积累中的应用 |
CN108192917A (zh) * | 2018-01-30 | 2018-06-22 | 广东开源环境科技有限公司 | 转蜈蚣草PvACR2基因的重金属超富集转基因工程水稻的创制及应用 |
CN108192915A (zh) * | 2018-01-30 | 2018-06-22 | 深圳市沃地污染修复技术有限公司 | 转蜈蚣草PvACR2基因的重金属超富集转基因工程油菜的创制及应用 |
CN112458098A (zh) * | 2020-12-03 | 2021-03-09 | 上海市农业科学院 | 一种来源于葡萄的耐镉基因Vvmrp1S及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070989A2 (en) * | 2000-03-22 | 2001-09-27 | Vlaamse Instelling Voor Technologisch Onderzoek (Vito) | Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
CN1433676A (zh) * | 2002-01-21 | 2003-08-06 | 中山大学 | 总dna导入培育富集重金属转基因植物的方法 |
-
2004
- 2004-10-12 CN CNB2004100808575A patent/CN100360559C/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001070989A2 (en) * | 2000-03-22 | 2001-09-27 | Vlaamse Instelling Voor Technologisch Onderzoek (Vito) | Genetically modified plants and plant cells comprising heterologous heavy metal transport and complexation proteins |
CN1433676A (zh) * | 2002-01-21 | 2003-08-06 | 中山大学 | 总dna导入培育富集重金属转基因植物的方法 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102190715A (zh) * | 2010-03-02 | 2011-09-21 | 中国科学院植物研究所 | 一种植物砷抗性相关的蛋白及编码基因及其应用 |
CN102190715B (zh) * | 2010-03-02 | 2013-05-01 | 中国科学院植物研究所 | 一种植物砷抗性相关的蛋白及编码基因及其应用 |
CN107475780A (zh) * | 2017-09-25 | 2017-12-15 | 中国计量大学 | 一种低温胁迫下福寿螺ssh文库的构建、鉴定方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1760204A (zh) | 2006-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Gray et al. | Molecular detection and quantitation of the red tide dinoflagellate Karenia brevis in the marine environment | |
CN101054411B (zh) | 玉米钙调磷酸酶b类似蛋白及其编码基因与应用 | |
Giordani et al. | Characterization and expression of DNA sequences encoding putative type-II metallothioneins in the seagrass Posidonia oceanica | |
CN102952822A (zh) | 丹波黑大豆c2h2型锌指蛋白基因stop1的植物表达载体及其应用 | |
CN107119048B (zh) | 桑假尾孢菌rDNA及其在桑假尾孢菌分子检测中的应用 | |
CN100360559C (zh) | 一种蜈蚣草abc转运蛋白及其编码基因与应用 | |
CN113046362B (zh) | 提高镉抗性镉含量减轻镉胁迫dna损伤的基因及其用途 | |
CN101230357A (zh) | 一种提高植物耐铝毒能力的植物表达载体及其应用 | |
CN109880829A (zh) | 大麦HvPAA1基因及其用途 | |
CN103044534B (zh) | 紫花苜蓿抗旱相关基因及其编码的蛋白和应用 | |
CN104480120A (zh) | 植物耐盐相关基因PpSIG2及其编码蛋白和应用 | |
CN102625834B (zh) | 参与植物中镉的蓄积的基因的利用 | |
CN114736907A (zh) | 扶桑绵粉蚧的蜡质合成基因PsFAR及其应用 | |
CN107459566A (zh) | 来源于百合的LhWDR蛋白及其编码基因与应用 | |
CN106967163A (zh) | 一种棉花GbDRP42734基因、编码蛋白及应用 | |
CN103524611B (zh) | 南方根结线虫食道腺特异基因Msp40及其编码蛋白和其应用 | |
Chen et al. | Strong genetic structure observed in Primulina danxiaensis, a small herb endemic to Mount Danxia with extremely small populations | |
CN102021188A (zh) | 白沙蒿△12脂肪酸脱氢酶(As FAD2)基因及用途 | |
CN102146125B (zh) | 与铵盐吸收相关的蛋白及其编码基因与应用 | |
CN101955522B (zh) | 一种花生二价铁转运蛋白及其编码基因与应用 | |
CN106947774B (zh) | 一种厚藤植物螯合肽合成酶IpPCS及其编码基因的应用 | |
CN106916213A (zh) | 一种蛋白AsT及其编码基因以及在植物耐逆性中的应用 | |
CN1944648B (zh) | 一种提高植物耐盐性的水稻Cyp2基因 | |
CN112094827B (zh) | 一种毛竹盐胁迫响应基因PeFeSOD2及其应用 | |
CN110655563B (zh) | 一种浒苔中硝酸盐转运蛋白体及其编码基因 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |